[PDF][PDF] First-in-human dose escalation of monalizumab plus durvalumab, with expansion in patients with metastatic microsatellite-stable colorectal cancer
J Clin Oncol, 2018•innate-pharma.com
First-in-Human Dose Escalation of Monalizumab Plus Durvalumab With Expansion in Patients
With Metastatic Microsatellite-Stable Page 1 First-in-Human Dose Escalation of Monalizumab
Plus Durvalumab With Expansion in Patients With Metastatic Microsatellite-Stable Colorectal
Cancer Neil H. Segal,1 Jarushka Naidoo,2 Giuseppe Curigliano,3 Sandip Patel,4 Solmaz
Sahebjam,5 Kyriakos Papadopoulos,6 Michael Gordon,7 Ding Wang,8 Ana Gómez Rueda,9
Xuyang Song,10 Xia Li,10 Shannon Marshall,10 Shaad Abdullah,10 Jennifer R. Diamond11 …
With Metastatic Microsatellite-Stable Page 1 First-in-Human Dose Escalation of Monalizumab
Plus Durvalumab With Expansion in Patients With Metastatic Microsatellite-Stable Colorectal
Cancer Neil H. Segal,1 Jarushka Naidoo,2 Giuseppe Curigliano,3 Sandip Patel,4 Solmaz
Sahebjam,5 Kyriakos Papadopoulos,6 Michael Gordon,7 Ding Wang,8 Ana Gómez Rueda,9
Xuyang Song,10 Xia Li,10 Shannon Marshall,10 Shaad Abdullah,10 Jennifer R. Diamond11 …
Background
Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting; June 1–5, 2018; Chicago, IL.
innate-pharma.com